|
|
|
Corporate Profile: Soricimed
| Summary: |
Soricimed is focused on the research and development of peptides that modulate ion channel activity for the treatment of patients with cancer or pain.
|
| Address (HQ): |
18 Botsford Street
Suite 201
Moncton, NB E1C 4W7
Canada |
| Phone
#'s (HQ): |
| Main |
(506) 872-2181 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
(506) 856-0414 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
